# FDA WARNING_LETTER - Bi-Coastal Pharma International - January 14, 2022

Source: https://www.globalkeysolutions.net/records/warning_letter/bi-coastal-pharma-international/9d69b93a-a4bd-41ab-bcb4-264b50e2661a

> FDA WARNING_LETTER for Bi-Coastal Pharma International on January 14, 2022. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: Bi-Coastal Pharma International
- Inspection Date: 2022-01-14
- Product Type: Drugs
- Office Name: Office of Pharmaceutical Quality Operations Division I

## Related Officers

- [Director of Investigations Branch](https://www.globalkeysolutions.net/people/nerizza-guerin/407df995-bd23-4948-82c2-e3bf8a6659b7)

Company: https://www.globalkeysolutions.net/companies/bi-coastal-pharma-international/38b9fd58-5145-4f23-9c94-1ba900477ef2

Office: https://www.globalkeysolutions.net/offices/office-of-pharmaceutical-quality-operations-division-i/798d6a62-d1f1-4f7c-8de3-465e277c13da